BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 22847494)

  • 1. Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction.
    Boslem E; Meikle PJ; Biden TJ
    Islets; 2012; 4(3):177-87. PubMed ID: 22847494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.
    Bellini L; Campana M; Mahfouz R; Carlier A; Véret J; Magnan C; Hajduch E; Le Stunff H
    Expert Opin Ther Targets; 2015; 19(8):1037-50. PubMed ID: 25814122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of sphingolipid metabolism: from synthesis to breakdown.
    Gault CR; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.
    Roszczyc-Owsiejczuk K; Zabielski P
    Front Endocrinol (Lausanne); 2021; 12():635175. PubMed ID: 33815291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells.
    Gurgul-Convey E
    Cells; 2020 Aug; 9(8):. PubMed ID: 32759843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Ceramide in Apoptosis and Development of Insulin Resistance.
    Kuzmenko DI; Klimentyeva TK
    Biochemistry (Mosc); 2016 Sep; 81(9):913-27. PubMed ID: 27682164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease.
    Nicholson RJ; Pezzolesi MG; Summers SA
    Front Endocrinol (Lausanne); 2020; 11():622692. PubMed ID: 33584550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis.
    Mignard V; Dubois N; Lanoé D; Joalland MP; Oliver L; Pecqueur C; Heymann D; Paris F; Vallette FM; Lalier L
    J Lipid Res; 2020 Jul; 61(7):1025-1037. PubMed ID: 32350079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.
    Bandet CL; Tan-Chen S; Bourron O; Le Stunff H; Hajduch E
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes.
    Garbowska M; Łukaszuk B; Mikłosz A; Wróblewski I; Kurek K; Ostrowska L; Chabowski A; Żendzian-Piotrowska M; Zalewska A
    J Cell Physiol; 2017 Oct; 232(10):2766-2775. PubMed ID: 28369933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids in mammalian cell signalling.
    Ohanian J; Ohanian V
    Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ceramide in diabetes mellitus: evidence and mechanisms.
    Galadari S; Rahman A; Pallichankandy S; Galadari A; Thayyullathil F
    Lipids Health Dis; 2013 Jul; 12():98. PubMed ID: 23835113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct insulin granule subpopulations implicated in the secretory pathology of diabetes types 1 and 2.
    Kreutzberger AJB; Kiessling V; Doyle CA; Schenk N; Upchurch CM; Elmer-Dixon M; Ward AE; Preobraschenski J; Hussein SS; Tomaka W; Seelheim P; Kattan I; Harris M; Liang B; Kenworthy AK; Desai BN; Leitinger N; Anantharam A; Castle JD; Tamm LK
    Elife; 2020 Nov; 9():. PubMed ID: 33164744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sphingolipid salvage pathway in ceramide metabolism and signaling.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sphingolipid-mediated apoptotic signaling pathways].
    Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
    J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipids related to apoptosis from the point of view of membrane structure and topology.
    van Blitterswijk WJ; van der Luit AH; Caan W; Verheij M; Borst J
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):819-24. PubMed ID: 11709081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in β-Cell Sphingolipid Profile Associated with ER Stress and iPLA
    Ali T; Lei X; Barbour SE; Koizumi A; Chalfant CE; Ramanadham S
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
    Wang G; Bieberich E
    Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solving the enigma: Mass spectrometry and small molecule probes to study sphingolipid function.
    Millner A; Atilla-Gokcumen GE
    Curr Opin Chem Biol; 2021 Dec; 65():49-56. PubMed ID: 34175552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.